Increased bilateral mastectomy for breast cancer treatment has generated an increased demand for bilateral breast reconstruction. This study examines changing patterns of reconstruction over the last decade to accommodate increased case volume and decreased morbidity associated with reconstruction. A single institution series of 3171 consecutive breast reconstruction cases of more than 10 years was divided into 2 periods, that is, 1999 to 2004 and 2005 to 2010. Bilateral breast reconstruction case volume increased 260% from 1999 to 2004 (n = 237) to 2005 to 2010 (n = 634). Mean patient age at diagnosis decreased by 7 years (P G 0.001). In 2005 to 2010, autologous reconstruction decreased from 60% to 26%, implant-based reconstruction increased from 40% to 74%. There was a noted increase in single-stage implant reconstruction and selective application of perforator flaps for bilateral autologous reconstruction (P G 0.001). Two-staged tissue expander reconstruction accounted for the greatest share of total cost (45%) in the later period. A younger patient demographic and increased case volume were accommodated through increased single-staged and prosthesis-based procedures.
B reast cancer is the second leading cause of cancer-related mortality in women, and women have a one in 8 lifetime risk of breast cancer. 1 The last decade has been associated with trends toward a younger patient age at diagnosis with breast cancer and increased contralateral prophylactic mastectomy (CPM). 2Y9 These trends have been attributed at large to advances in the field of oncology including the advent and widespread implementation of BRCA1/2 testing, and improved mammography surveillance programs. 5Y12 In addition to this documented increase in CPM, there is evidence to suggest that CPM, bilateral mastectomy (BM), and younger patient age are positive predictors for subsequent breast reconstruction. 2,5Y13 In a 2011 study examining trends in reconstruction based on 389 survey responses from members of the American Society of Plastic Surgeons, Gurunluoglu and colleagues 14 found that 16% of bilateral reconstructions were performed after prophylactic mastectomy. Furthermore, a 2010 retrospective chart review demonstrated a significant increase in CPM from 0% to 20% (P G 0.001) from 2000 to 2008, and found that breast reconstruction was more common in women undergoing prophylactic mastectomy. 5 A 2011 study of 110 patients found that 37% of women who tested BRCA negative still chose to undergo prophylactic contralateral mastectomy and breast reconstruction. 16 Although there are a number of studies to support the trend toward an increased volume of breast reconstruction, a comprehensive analysis of the evolution of patterns of reconstruction in the context of advances in oncologic treatment and change in patient demographic is lacking.
The National Committee for Quality Assurance 2011 report estimates the cost of breast cancer treatment to be approaching 7 billion dollars per year. 17 A 2011 study used a Markov model to compare cost of CPM against routine surveillance in women after diagnosis with unilateral breast cancer. This study demonstrated that, although the mean cost of treatment was comparable between groups ($36,594 for CPM vs $35,182 for surveillance), the CPM group gained 21.22 mean quality-adjusted life years compared with 20.93 for surveillance alone. 18 In the current climate of health care reform, given the significant proportion of individuals who pursue reconstructive options after CPM, cost considerations for breast cancer treatment and reconstruction are increasingly pertinent. Although cost alone should not dictate reconstructive method, cost data when interpreted in conjunction with data on patterns of reconstruction, can play an important role in identifying necessary areas for growth and changes to subsequently direct allocation of resources at institutional and national policy levels.
In this study, 2 consecutive 5-year periods were selected arbitrarily [period A (2000Y2005) and period B (2005Y2010)]. Although this selection allowed for the characterization of 2 groups of sufficient size and follow-up, there are some important advances in oncologic and plastic surgery practice that occurred during this 10-year period that may have influenced the patterns of reconstructive practice observed in each period, such as the popularization of single-stage implant-based breast reconstruction using acellular dermal matrix (ADM) and the deep inferior epigastric perforator (DIEP) flap. 19, 20 There are a number of factors that contribute to the selection of an appropriate type of breast reconstruction for a patient, not the least of which is the advent of new reconstructive procedures and advances in tumor extirpation techniques. The skin-sparing mastectomy, first described by Toth and Lappert 21 in 1991, introduced an approach to mastectomy that allows for preservation of the skin envelope to facilitate immediate breast reconstruction with a superior aesthetic result. 22 Although there was some initial concern over a potential adverse impact on survival associated with skin-sparing mastectomy, the results of several studies have demonstrated rates of local recurrence (ranging from 0% to 7%) that are comparable to patients with either delayed reconstruction or no reconstruction, thus facilitating widespread implementation of the skin-sparing mastectomy technique. 23Y25 Similar to the development of the skin-sparing mastectomy, the nipplesparing mastectomy is an approach to tumor extirpation that has resulted in improved aesthetic outcome and, perhaps most importantly, increased patient satisfaction after breast reconstruction. 26, 27 Although some controversy exists with regard to the safety of this procedure for breast cancer patients, there is a great deal of evidence to support the safety of preservation of the nipple-areolar complex in properly selected patient groups. 28Y36 Both the skin-sparing and nipplesparing mastectomy techniques have facilitated immediate breast reconstruction, thus enabling patients to avoid a second reconstructive procedure (ie, tissue expander placement and exchange versus immediate implant placement), and improving cosmetic outcome because of preservation of the skin envelope. 22,26Y28 In addition to the aforementioned advances in the field of surgical oncology, the creation of 2, now commonly practiced, plastic surgery techniques took place around the period of this study. In 1994, Allen and Treece 20 published the first case report describing the successful use of a DIEP free flap in breast reconstruction. This procedure gained popularity as an ''improved TRAM flap,'' allowing for autologous tissue reconstruction without the functional deficit associated with compromise of the rectus abdominis muscles. 37Y39 In 2005, the first case report was published, describing the use of ADM in the formation of an inferolateral sling for inferior coverage of a breast implant. 19 Whereas ADM was previously used in revision procedures to repair contour abnormalities such as rippling, this technique afforded surgeons the opportunity for immediate reconstruction with control of implant position, decreased postoperative pain, decreased donor-site morbidity, and improved cosmesis. 40Y45 Together, the DIEP flap and description of the use of ADM in breast reconstruction afford plastic surgeons a greater range of reconstructive options to offer their patients.
This retrospective study described the change in patterns of reconstructive practice to accommodate increase in case volume changing patient demographics and concerns regarding morbidity associated with reconstruction. Moreover, this study aimed to define how the shift in patterns of reconstructive methods has translated to changes in the cost of reconstruction during the last decade.
METHODS

Study Subjects
This retrospective study is a consecutive case series collected from a single multidisciplinary tertiary academic medical center. The study was approved by the Massachusetts General Hospital Institutional Review Board. Data was collected from a clearinghouse database termed the Research Patient Data Registry (RPDR). The RPDR is a secure repository of electronic medical data that dates from 1978 to the current date, updated continuously. The RPDR was used to identify all patients who have received unilateral mastectomy (UM) or 
Statistical Analysis
Data were analyzed using SAS 9.2 for statistical significance, which was defined as P G 0.05. Two-population z test was used to determine proportions of 2 populations, and W 2 test was used to determine the distribution of procedures. Once F test confirmed that the variance between 2 populations was the same, 2-sided Student t test with equal variance but unequal sample size was used for continuous variables.
Outcome Analysis
A total of 3171 patients fulfilled the criteria of having undergone UM or BM and breast reconstruction (including immediate and delayed reconstructions). Patient characteristics included demographic information, comorbid conditions, breast cancer risk factors, family history, and tumor characteristics ( Table 1 ). Only the primary type of breast reconstruction was considered, which is the first reconstruction performed after mastectomy ( Table 2 ). Cases where the first type of reconstruction was replaced with another reconstructive type were captured under revision and complication analyses. In cases of staged reconstruction using tissue expander followed by implant exchange, the second-stage procedure was recorded as ''additional reconstructive procedure'' in Table 3 . Complication end points of seroma or hematoma, infection or skin necrosis, removal of prosthesis due to infection, rupture, and other revisions were also recorded. Notably, complication data were obtained for both inpatients and outpatients. All patients included in this study were followed up for a minimum of 6 months.
For all patients included in this study, choice of reconstructive procedure followed a balanced analysis of variables such as timing of mastectomy and reconstruction, history of previous breast radiation or need for postmastectomy chest radiation, patient anatomy (including availability of tissue, breast size before mastectomy, and integrity of skin after mastectomy in the case of immediate reconstruction), and patient wishes surrounding recovery time and desired breast size. Notably, surgeon contracts did not motivate choice of reconstructive procedure.
Cost Analysis
This study uses a cost-minimization analysis in which the costs associated with different interventions are compared without direct attention to the health outcomes associated with the various interventions. This analysis assumes the perspective of the hospital, and examines cost data (the actual cost to the hospital) rather than hospital charges, because charge data are arbitrary given that thirdparty payers generally do not pay the full amount billed, and the payment amounts vary greatly among payers. To enable a valid comparison of changes in cost over time, the net present value of cost was used in this cost analysis study. This economic evaluation is not comprehensive and is intended as a preliminary analysis, which may form a foundation for a subsequent detailed cost-utility analysis.
In performing this cost analysis, a sample of patients (n = 10) was taken from the computer-generated patient list for each of the following procedure groups: DIEP flap, free transverse rectus abdominis myocutaneous (TRAM) flap, pedicled TRAM flap, silicone implants with ADM, tissue expander, and tissue expander with ADM. In all cases, unilateral and bilateral procedures were grouped and analyzed separately. The total hospital cost was obtained, which included all costs encountered by the hospital from the surgery date (same-day admission) to the discharge date (ie, including pharmaceuticals, hospital stay, anesthesia, operating room time, etc). In the case of the tissue expander procedures, both the placement of the tissue expander, and the implant exchange procedure were included in the total hospital cost.
The mean procedural cost was multiplied by the number of patients receiving said procedure during each period to evaluate how the changing reconstructive trends impacted hospital cost (thus, establishing a sum of normalized cost units).
In comparisons of mean procedural cost and cost per period, 2-tailed t tests were used at a 95% confidence interval to evaluate differences between groups. Total costs across periods (sum of normalized cost units) were compared using z scores, where the difference between groups was divided by the square root of the difference of variances, an equation derived from the law of probabilities. Of note, hospital policy precludes the publication of actual dollar amount costs for procedures. As such, all cost values were divided by the value of the least costly procedure (unilateral silicone implants with ADM) to obtain a unit ratio through which procedural costs could be compared.
RESULTS
Changing Characteristics of the Patient Population
Patient characteristics between periods A (1999Y2004) and B (2005Y2010) differ in patient age, radiation treatment, and genetic testing ( Table 1 ). Patients of the BM groups are younger on average than patients in the UM group, a trend seen in both periods A and B (57 vs 64 and 51 vs 59 years old, P G 0.001) ( Table 1 ). The mean age at diagnosis in period B is 7 years younger than period A, down from 63 to 56 (P G 0.001). The UM patients are more likely to receive radiation when compared to BM patients in periods A and B (53.2% vs 24.0% and 36.5% vs 23.5%, P G 0.001) ( Table 1 ). Patient medical conditions and personal history of breast cancer risk factors are similar between the UM and BM groups within periods A and B, and between periods A and B.
In contrast, family history of breast cancer is significantly different between the UM and BM groups in period B, but not period A. The BM patients are more likely to have first-and second-degree relatives with breast cancer compared to UM patients (P G 0.001) ( Table 1 ). In addition, not only are BM patients more likely to be tested for BRCA gene mutation, but they are also more likely to test positive, which is again seen in both periods A and B (P G 0.001). There is a 3-fold increase in percentage of BM patients with positive BRCA mutation from periods A to B (16.9% vs 5.3%, P G 0.001) ( Table 1) .
Meanwhile, there is a 2.6-fold increase in the number of patients receiving BM from period A to period B (237 vs 634, P G 0.0001) ( Table 2 ). In contrast, the number of patients undergoing UM did not change significantly (Table 2) . Concurrent with the introduction of genetic testing for BRCA1/2, there is an increase in the number of patients undergoing BM in period B (P G 0.001). As this group was also significantly younger than that observed in period A (P G 0.001), it is plausible that this trend may be attributable to an increased incidence of prophylactic mastectomy.
Shift in Reconstruction Paradigm
We hypothesized that a shift in the patient demographics and increased incidence of BM may be correlated with a shift in the breast reconstruction paradigm, which was in fact observed in this study ( Table 2 ). Reconstructive procedures for BM patients have a significantly different distribution than that for UM patients. Patients who undergo BM are more likely to undergo reconstruction than patients after UM, in both periods; 82.6% vs 51.3% in period B (P G 0.001), and 62.0% vs 40.0% in period A (P G 0.001) ( Table 2) . Patients are more likely to choose postmastectomy reconstruction in period B (62.1% vs 43.9%, P G 0.001).
During period A, the UM group favors autologous reconstructive options (73%), with pedicled TRAM flap as the most common method (52%) and tissue expander placement was the second most common method (21.5%) ( Table 2 , Fig. 1 ). In fact, if the pedicled and free TRAM flap groups are combined, reconstruction with abdominal based flap is performed in 62% of UM cases and only 19% of BM cases (Table 2, Fig. 2) .
In contrast, the most common reconstructive option in the BM group in period A was tissue expander placement, accounting for 65.3% of all reconstruction in this group (Table 2, Fig. 2 ). In the period A BM group, pedicled TRAM was the second most common procedure (14.3%), followed closely by immediate single-stage implant-based reconstruction (11.6%) ( Table 2, Fig. 2) .
The total volume of reconstruction cases increased between periods A and B, from 589 cases to 1137 cases, a significant increase of 193% (Table 2 ). In period B, the percentage of autologous reconstruction dropped sharply (60% decreased to 26%), whereas implant-based reconstruction became dominant (40% increased to 74%). During period B, 2 new methods of breast reconstruction were introduced at our institution, namely, immediate implant reconstruction with ADM hammock and DIEP free flap procedure.
Unlike period A, where pedicled or free TRAM were the most common reconstructive options in the UM group, prosthesis-based reconstruction became more common in period B, accounting for 67% of UM cases (Table 2, Fig. 3 ). The increase in tissue expander and immediate implant use in period B was associated with the availability of ADM, which allowed placement of tissue expander with significant fill volume, or single-stage reconstruction with implant. Meanwhile, prosthesis-based reconstruction continued to be the dominant type of reconstruction in BM cases during period B, accounting for 84% of all reconstructive methods in BM cases ( Table 2 , Fig. 4 ). Tissue expander (37.8%) was the most common prosthesis-based reconstruction after UM, followed by immediate implant with ADM (29.2%) and tissue expander with ADM (6.7%).
Period B saw an overall reduction in the use of autologous reconstructive methods after UM. Within the unilateral reconstruction group in period B, pedicled TRAM remained the dominant method (19.9%), followed by free TRAM (6.5%) and DIEP (4.7%) flaps. Although the DIEP flap was not widely used for UM reconstruction ( Table 2, Fig. 3 ), the DIEP flap accounted for 38% of all autologous methods in the BM group (5.5% of total BM reconstruction methods), with a reduction in the use of pedicled TRAM flap in the BM group versus UM group (19.9% vs 3.6%, P G 0.001) ( Table 2 , Fig. 4 ).
Eliminating the effect of time and comparing only the total reconstruction patterns after BM versus UM, bilateral reconstructions more often included immediate tissue expander placement (43.8% vs 26.4%, P G 0.001), and silicone implant placement with ADM (22.8% vs 13.6%, P G 0.001). Conversely, bilateral cases are less likely to use pedicled TRAM flap (6.0% vs 33.4%, P G 0.001) and latissimus dorsi flap (2.4% vs 5.7%, P G 0.001).
In summary, during the last decade, the number of prosthesisbased reconstruction, with tissue expander/ADM (6.9% vs 0.0%, P G 0.001), and immediate implant/ADM (25.9% vs 0.5%, P G 0.001) increased significantly. Overall, there was a sharp decrease in use of pedicled TRAM flaps (42.6% vs 12.4% P G 0.001) and latissimus dorsi flaps (9.0% vs 2.0%, P G 0.001) in period B. Although the muscle-sparing DIEP flap procedure was introduced in period B (5.1% vs 0.0%, P G 0.001), this method was selectively used in cases of BM autologous reconstruction, whereas pedicled TRAM remained the dominant method of autologous reconstruction after UM.
Complication and Revision Rates
Increase in the application of stage breast reconstruction using tissue expander incurred significant increase in the second-stage procedure of implant exchange, 139 in period A versus 406 in period B (Table 3 ). In both periods A and B, contralateral mastopexy was more often performed for UM patients (P G 0.001). There is no significant difference in the number of nipple areolar reconstruction between groups (Table 3) .
Despite significant shifts in reconstructive methods between periods A and B, there was no observed increase in complication rates. There was no significant difference in the incidence of seroma or hematoma formation between the 2 periods. The total percentage of infection or skin necrosis remained the same during periods A and B (10.5% vs 10.3%, P = 0.879). There were no statistically significant differences in revision rates or other complication rates when comparing between the UM and BM groups across period A. During period B, BM patients had increased rates of revision compared to UM patients (26.9% vs 22.7%, P G 0.01).
FIGURE 3.
Distribution of reconstructive methods in period A (1999Y2004) after BM. Interestingly, the distribution of reconstructive methods for bilateral reconstruction is opposite to that observed for unilateral reconstruction in period A; bilateral reconstruction in period A was associated with a predominance of prosthesis-based reconstruction (78%), whereas only a minority of cases (23%) relied on autologous reconstruction. Within prosthesis-based reconstruction, TE accounted for 66% of reconstruction, followed by single-stage implant reconstruction (Immed. Implant, 12%). Autologous reconstruction methods were comprised of p TRAM (14%), f TRAM (5%), and lat (2%) flaps. Percentages are rounded to the nearest whole number. 
Cost Analysis
A cost analysis was performed to determine whether the observed shift in reconstructive paradigm resulted in significant differences in cost. Fixed and variable cost information was obtained for all types of reconstructive procedures, encompassing all aspects of the surgery and hospitalization. In this preliminary analysis, only the cost of the initial primary reconstructive procedure was examined. Cost associated with revision procedures was not evaluated in this study. In cases of staged reconstruction using tissue expanders, the sum of the costs of the initial tissue expander placement and the subsequent exchange for implant were combined ( Table 4 ).
As expected, bilateral reconstruction was associated with higher cost for all reconstruction types, with increased use of resources ranging from longer operating room time and cost of additional prosthetic devices. Notably, single-stage reconstruction with ADM and silicone implant was the least costly procedure type, and DIEP was the most costly procedure type (Fig. 5, Table 4 ). Singlestage reconstruction with silicone implant and ADM was less costly than staged reconstruction with tissue expander placement, in both unilateral and bilateral cases ( Table 4 ).
The procedure that made up the greatest proportion of total cost in period A was unilateral pedicled TRAM flap (42% of total cost in period A), whereas the bilateral tissue expander procedure made up the greatest proportion of total cost in period B (26% total cost in period B). In period B, tissue expander placement accounted for 45% of total reconstruction cost. The total cost of reconstruction was higher in period B than A (1171.80 vs 633.20, P G 0.05), again resulting from a higher case volume in period B, greater number of bilateral reconstruction procedures, and the introduction of the DIEP flap, the most costly procedure ( Table 5 ).
DISCUSSION
Breast reconstruction procedures are among the most common procedures in most adult academic plastic surgery centers. In a practice environment where several reconstructive options are available, the selection of a reconstructive method should be tailored to an individual's anatomy, medical and surgical history, and the preferences of the patient. This study sought to determine and describe the manner in which trends toward changing oncologic practice and patient demographic are associated with evolution in selection of reconstructive procedures. Although changes in reconstructive practice patterns are subject to the practice environment, hospital resources, and skill set of the surgical group, we believe our experience to be typical of most urban academic centers, and posit that this report of changing patterns of reconstruction and associated preliminary cost analysis may be informative to other centers.
This study demonstrated a 2.6-fold increase in the incidence of prophylactic mastectomy during the last decade, associated with increased volume of bilateral breast reconstruction, in a patient population that is younger (by 7 years). Although DIEP flap reconstruction was introduced in period B, it was selectively used in bilateral autologous reconstruction, where donor-site morbidity is most prominent. Meanwhile, prosthesis-based reconstruction volume increased significantly, especially single-stage implant reconstruction using silicone implant and ADM. The cost of single-stage implant reconstruction also compared favorably against 2-staged tissue expander implant reconstruction (Table 4 ). However, the 2-staged tissue expander implant reconstruction was the highest volume procedure and accounted for the greatest share of total cost during period B. Recognizing these cost trends is important, so that efforts to reduce cost may be best targeted toward reducing the cost of prosthesis-based reconstruction, such as shifting from 2-stage to single-stage procedures when possible, or reducing the direct costs of implants and ADM from suppliers.
Although physician advice was cited by patients as a reason to elect BM in other studies, this issue was not specifically addressed in this current study. 3, 8 The surgical oncology team remained the same throughout periods A and B and therefore physician advice was a constant rather than measurable variable. Concern for optimal cosmetic outcome and the greater possibility of immediate restoration of symmetric breast mounds in a single procedure may contribute to the increased likelihood of BM patients selecting reconstruction compared to UM patients. Some studies have demonstrated desire for symmetry to be one of the reasons to choose BM over UM. 46Y51 Furthermore, these studies suggest that BM patients report higher satisfaction, minimal change in quality of life, and fewer regrets following prophylactic reconstruction. 46Y49 Therefore, optimizing aesthetic outcomes may be a deciding factor for BM.
Notably, the choice of reconstructive procedure was based on a treatment approach to minimize associated morbidity, in which multiple variables such as patient anatomy, desired postoperative breast size, radiation treatment, and timing of reconstruction were considered. Although there is evidence to suggest that reimbursement motivates choice of reconstructive method at many institutions, this is not the case at our institution. 51, 52 This is supported by the fact that the DIEP flap, a procedure associated with the most favorable contract in many regions of the country, was not the dominant procedure at this tertiary care center, despite the fact several high-volume microsurgeons trained in the procedure are part of the reconstructive team. Notably, whether the rectus abdominis is truly spared in a DIEP procedure, or whether sacrifice of the rectus abdominis produces significant functional morbidity remains controversial, and depends on surgical technique and patient selection, at a minimum. 53 In this series, DIEP flap was implemented in cases of bilateral autologous reconstruction, where division of both rectus abdominis muscle origins in bilateral TRAM would result in significant functional consequence.
The advent of immediate reconstruction with ADM was instrumental in the evolution of reconstructive trends to meet the new demands on postmastectomy reconstruction. There was an increase in reconstruction with ADM and silicone implant during period B compared to A, after both UM and BM. Cited advantages of using ADM as an inferolateral hammock supporting either tissue expander or silicone implant include favorable aesthetic outcomes, maximizing expander filling volume, decreased dissection of rectus and serratus fascia, and improved control of the implant pocket. 50Y52 In general, implant-based reconstruction was the more popular option after BM compared to UM. Preference for implant-based reconstruction over autologous tissue after BM may be due to lack of sufficient autologous tissue to restore BM defects, or decreased tolerance for donorsite morbidity in a younger patient group.
It is important to note that, despite the dramatic shift in reconstructive methods from TRAM flaps as the dominant method in period A to tissue expanders and ADM applications in period B, the complication rates remained low. Adoption of new methods of singlestage reconstruction using ADM did not generate increased rates of implant complications.
Limitations of this study include unequal follow-up between periods A and B, inability to determine causality (this is a retrospective review study), and potential limited external validity associated with examination of 1 institution. All the data included in this study originate from a single institution, other hospitals with institutionspecific surgeon preferences and resources may experience distinct patterns of breast cancer treatment and reconstruction. Lastly, although this preliminary cost analysis reveals trends in cost over time, it does not consider the advantages and disadvantages of each procedure for the patient. A future cost-utility analysis (as compared to the cost-minimization analysis performed in this study) might account for important variables such as quality-adjusted life years, complication and revisionary procedure rates, and other intangible outcomes (eg, patient self-image, self-confidence, satisfaction, and pain after procedure). 54, 55 Strengths of this study include the comprehensive perspective gained from a detailed analysis of 3171 cases. This study demonstrated statistically significant trends of increasing BM procedures, decreasing patient age at diagnosis, and associated changes in reconstructive methods. To our knowledge, no study has demonstrated the changes in oncologic and reconstructive practice over a decade, with a preliminary cost analyses as are presented here. In a 2009 prospective case series, Beahm and Walton 56 examined 3517 cases performed between 1990 and 2005. The results from this case series were comparable to the earlier period presented in the study from our institution, wherein there was a predominance of autologous-based reconstruction after UM, and a predominance of implant-based reconstruction after BM. 56 Although we report our single-institution experience, our results are validated by a recent national survey of 489 members of the American Society of Plastic Surgeons, which found overall increases in prosthesis-based reconstruction, preference for DIEP flap for bilateral autologous reconstruction, and continued use of TRAM flap for unilateral autologous reconstruction. This national survey study presented by Gurunluoglu and colleagues 14 validates the data presented from our case-series, and suggests that our single-institution experience is representative of the national experience. 
